McKesson

At McKesson Ventures, we help entrepreneurs in the healthcare technology and services space build and scale businesses that tackle some of the toughest challenges in healthcare. We look for people, like us, who are passionate about making a difference and rethinking what’s possible in healthcare. We have deep industry experience as investors and operators who have walked in your shoes. And, we have the insights and industry connections that come with being part of one of the largest healthcare companies in the world. We are highly respected and trusted by both the entrepreneurs and investors we work with – and look forward to continuing to partner with visionary leaders that have bold ideas. We are financially minded, first and foremost, investing in big markets, talented teams and great products. But we also bring the insights and connections that come with being part of McKesson, one of the country’s leading healthcare organizations. We help our portfolio companies access McKesson, as well as tap into our relationships with key stakeholders throughout the healthcare ecosystem including pharmacies, payors, providers and manufacturers. Our Values Venture firms don’t often talk about their values, but we do. We believe finding the right investors for your company is one of the most critical decisions an entrepreneur will make. We promise to be open and honest at every stage of our relationship. We are aware of what we know and what we don’t know – but most importantly, we know how to find the answers. We will be there for the ups, the downs and everything in between. We work hard to support you – bringing our network, experience and insights – because we are also passionate about making the healthcare system work better – for everyone. About McKesson McKesson has a long history of innovation and excellence within health care dating back to 1833 when it created the first national drug distribution system in the United States. Since then we’ve grown, evolving into one of the largest healthcare companies in the world with over $220 billion in revenue. While distribution is still at the core of what we do, we have become true partners with our customers leveraging technology, data and analytics to deliver the best care possible. We have a deep understanding of what it takes to scale innovation in healthcare and continually look for innovative ideas and partners to make healthcare more efficient, effective and human.

At Johnson & Johnson, we’re on a mission to change the trajectory of health for humanity. That starts by creating the world’s healthiest workforce. Through cutting-edge programs and policies, we empower the physical, mental, emotional and financial health of our employees and the ones they love. As such, candidates offered employment must show proof of COVID-19 vaccination or secure an approved accommodation prior to the commencement of employment to support the well-being of our employees, their families and the communities in which we live and work.

Pureland Global Venture is a direct investment fund and part of the Pureland Group which targets impact investment deals in the medical technology sector. We are Singapore-based with a focus in APAC, India and the US. The fund deals with early-stage companies who have potential to inject value into the patient care system, save lives and reduce gaps in the supply and demand chains. Since we were established, we have invested in multiple medical sectors in both medical devices and ML-based solutions. MISSION - WHAT WE WANT TO ACHIEVE Established with the goal of giving people access to healthcare and also providing them with clinical choices, our mission is to bring medical solutions and savings to 100 million people around the world. We strongly believe in people who don’t just care about profit and who want to make the world a better place by solving real issues and pushing forward the latest evolution in medical technology. We envision bringing together impactful start-ups, commercial partners, insightful advisors and clinical providers in order to build a sustainable foundation for affordable, accessible and high-quality healthcare. WHY HEALTHCARE? Worldwide healthcare spending is expected to continue to rise at an alarming rate with a slight difference in some countries. Of all the leading factors, life expectancy appears to still be on the rise. By 2050, 1/6 people in the world will be over the age of 65 (16%), an increase from 1/11 in 2019 (9%). The number of people aged over 80 is projected to be 426 million by 2050 according to the United Nations population prospects. As we are entering a smart-health generation, the ecosystem demands more cost-effective solutions and appropriate treatments which can be delivered at the appropriate time and location. Clinicians use technology to give more holistic solutions to an aging population and provide more accurate diagnostics. Care delivery stakeholders use data and communicate more effectively and efficiently. Patients are involved in their own treatment plans and more healthcare access is delivered to people who did not previously have access. Unfortunately, we still face issues such as the increasing cost of healthcare, aging population, limited resources and shortages of healthcare professionals in various parts of the world. In order to combat these problems, government support and spending alone is not enough. We believe that these shortages can be filled by technology, which can be our solution for ensuring sufficient healthcare for future generations. This is also the reason why we are keen on enterprises which can provide solutions to combat these issues and create positive changes in the smart-health era. Founded in Singapore, we hope to be able to leverage the geographical advantage of Asia, and put together growth opportunities for these technologies which will make them accessible globally in the long term. WE SUPPORT START-UPS POST INVESTMENTFOUNDER SUPPORT: Start-ups regularly face critical decision-making as businesses grow from continuous market feedback and unexpected situations. We understand how difficult it can be and we will work together with the founders as a team in order to assist them with scaling their company, whether from networking referrals at the R&D stage, business strategy improvement at the growth stage, or EBITDA optimisation at a later stage. We offer support to founders for the optimisation of team structure as their businesses grow so they can overcome challenges and compete globally. MANUFACTURING SUPPORT: Manufacturing is one of the most crucial aspects of any device company, but it is often where mistakes are made. We advise our companies who experience manufacturing challenges from prototyping to mass production. In order to achieve this, we provide strategic value to our portfolio companies by connecting them to cost-effective manufacturing partners throughout the plastic, PCBA, silicon/rubber and final assembly industries. Our partners are high-mix and low-volume suppliers who understand the challenges of start-ups. Outside of production, we assist companies with lower case costing, set-up and management. GOVERNANCE: Establishing a good corporate culture and necessary internal control will mitigate business losses from major risks and lay the foundations for a company to improve. In a later stage funding cycle, correct corporate governance and internal control are paramount before larger funds buy into the company’s vision and growth story. We have a complete understanding of control and our networks are comprised of global experts in financial knowledge and risk assurance who can work together with our companies. FUNDRAISING: We typically fund companies while they are still young, from their seed to their series A round. Given the heavy research and development nature of medical technology companies, they usually require additional funding in order to boost their business quickly. Post-investment, we will not only collaborate on budgets and milestone adjustments but will more importantly offer assistance with financial modeling and revenue projection. This ensures that companies gain a higher chance of future investment. Finally, we work with other larger funds all over the world who specialise in revenue growth in order to understand their needs when they select their investment targets. EXIT: We seek founders with longer-term goals and a desire to take their companies to global players. Given our evergreen nature and flexible exit strategy, we are well suited to the long operation cycle of healthcare companies. At the same time, we understand and respect that some founders have a shorter term goal of M&A to boost market shares, expand business services or leverage bigger players to scale the company. We are experienced in company buy-out considerations and offer our support to founders as long as the company fits within our investment mandate.

Through its activities, Technology Ventures facilitates promising inventions to improve the quality of life for patients around the world. The mission of Technology Ventures is to promote the commercial development of Cedars‑Sinai research into products and services that advance healthcare and improve patient wellbeing. Technology Ventures actively seeks industry partners to develop these technologies and works to establish mutually beneficial long‑term relationships.

We partner with companies that create entirely new markets. For more than 25 years, and longer than almost any other investor in the country, our Principals have financed and helped build more successful healthcare industry "firsts" and companies that became market leaders. We invest on behalf of many of the largest healthcare organizations in the country, many of healthcare's most accomplished senior executives, and an outstanding group of global institutional investors. Our Principals have worked with strategic investors for longer than almost anyone in the industry. Collectively, Health Velocity Capital’s investors represent organizations that. INSURE MORE THAN 175M AMERICANS OPERATE >700 HOSPITALS PROVIDE PHARMACY & PBM SERVICES TO 75% OF THE NATION EMPLOY 5.0M AMERICANS GENERATE $2.1T IN REVENUE We leverage these relationships to help drive revenue and build teams In a highly process-driven and symbiotic manner, our Principals have used their networks to tangibly create equity value at more than 95% of the companies with which they have partnered. 10,000+ CONVERSATIONS WITH STRATEGIC INVESTORS 1000+ COMPANIES DISCUSSED $40B+ EQUITY VALUE CREATION 100+ EXECUTIVES PLACED 200+ COMMERCIAL RELATIONSHIPS FACILITATED We’re an investment firm that is driven by purpose, a clear mission, and an important set of core values Our mission is to generate outstanding financial returns while being the preferred innovation partner of entrepreneurs and investors working toward a more affordable, sustainable, consumer-friendly healthcare system.

ilde Healthcare is headquartered in Utrecht (the Netherlands) with two local offices in Frankfurt (Germany) and Cambridge (USA). One firm with two fund strategies Gilde Healthcare is a specialized healthcare investor managing with two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund invests in innovative companies active in healthtech and therapeutics in Europe and North America. The Private Equity fund participates in profitable European lower mid-market healthcare companies including healthcare providers, suppliers of medical products and service providers to the healthcare sector. 2 fund strategies Gilde Healthcare is a specialized European healthcare investor managing €2 billion across two fund strategies: Venture&Growth and Private Equity. Venture&Growth: The Venture&Growth fund is focused on investments in innovative companies active in healthtech and therapeutics based in Europe and North America. Private Equity: The Private Equity fund is focused on profitable European healthcare providers, suppliers of medical products and service providers active in the lower mid-market with an EBITDA between €2-15 million.